Upgrade to SI Premium - Free Trial

Sutro Biopharma Inc. (STRO)

24.15 -0.95 (3.78%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Stifel Starts Sutro Biopharma (STRO) at Buy August 6, 2026 4:07 PM - StreetInsider Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: BlackRock, Inc. July 30, 2026 11:20 AM - SEC Filing Truist Securities Assumes Sutro Biopharma (STRO) at Buy June 11, 2026 6:06 AM - StreetInsider Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Wigginton Jon Marc June 9, 2026 4:25 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Petree Daniel H June 9, 2026 4:24 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: PANEK JAMES P June 9, 2026 4:22 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Lobacki Joseph M June 9, 2026 4:20 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Jagpal Sukhi June 9, 2026 4:18 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Hunter Heidi June 9, 2026 4:17 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: Dybbs Michael June 9, 2026 4:15 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 05 Filed by: MATSUI CONNIE June 9, 2026 4:13 PM - SEC Filing Form 8-K SUTRO BIOPHARMA, INC. For: Jun 05 June 8, 2026 4:01 PM - SEC Filing Form 4 SUTRO BIOPHARMA, INC. For: Jun 02 Filed by: Chow Gregory K. June 2, 2026 4:16 PM - SEC Filing Barclays initiates oncology-focused biotechs with positive outlook May 28, 2026 11:05 AM - StreetInsider Barclays Starts Sutro Biopharma (STRO) at Overweight May 28, 2026 3:36 AM - StreetInsider Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: Samsara BioCapital, L.P. May 15, 2026 4:45 PM - SEC Filing Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Kynam Capital Management, LP May 15, 2026 4:02 PM - SEC Filing Wedbush Upgrades Sutro Biopharma (STRO) to Outperform May 15, 2026 6:34 AM - StreetInsider Sutro Biopharma Inc. (STRO) Misses Q1 EPS by 294c May 14, 2026 4:56 PM - StreetInsider Form 10-Q SUTRO BIOPHARMA, INC. For: Mar 31 May 14, 2026 4:31 PM - SEC Filing Form 8-K SUTRO BIOPHARMA, INC. For: May 14 May 14, 2026 4:16 PM - SEC Filing Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Affinity Asset Advisors, LLC May 14, 2026 4:14 PM - SEC Filing Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights May 14, 2026 4:05 PM - Globe NewsWire Full Article List